• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于术前增强胸部 CT 提取的放射组学特征诊断三阴性乳腺癌。

Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography.

机构信息

Department of Radiology, Linyi Central Hospital, Linyi, China.

Department of Healthcare, Linyi Central Hospital, Linyi, China.

出版信息

BMC Cancer. 2020 Jun 22;20(1):579. doi: 10.1186/s12885-020-07053-3.

DOI:10.1186/s12885-020-07053-3
PMID:32571245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7309976/
Abstract

BACKGROUND

To explore the diagnostic value of radiomics features of preoperative computed tomography (CT) for triple negative breast cancer (TNBC) for better treatment of patients with breast cancer.

METHODS

A total of 890 patients with breast cancer admitted to our hospital from June 2016 to January 2018 were analyzed. They were diagnosed by surgery and pathology to have mass and invasive breast cancer and had contrast-enhanced chest CT examination before operation. 300 patients were randomly selected for the study, including 100 TNBC and 200 non-TNBC (NTNBC) patients. Among them 180 were used in discovery group and 120 were used in validation group. The molecular subtypes of breast cancer in the patients were determined immunohistochemistrially. Radiomics features were extracted from three dimensional CT-images. The LASSO logistic method was used to select image features and calculate radiomics scores. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of radiomics scores for TNBC.

RESULTS

Five image features were found to be related to TNBC subtype (P < 0.001). These image features based-radiomic signatures had good predictive values for TNBC with the areas under ROC curve (AUC) of 0.881 (95% CI: 0.781-0.921) in the discovery group and 0.851 (95% CI: 0.761-0.961) in the validation group, respectively. The sensitivities and specificities were 0.767, and 0.873 in the discovery group and 0.785 and 0.915 in the validation group.

CONCLUSIONS

Radiomic signature based on preoperative CT is capable of distinguishing patients with TNBC and NTNBC. It adds additional value for conventional chest contrast-enhanced CT and helps plan the strategy for clinical treatment of the patients.

摘要

背景

探索术前计算机断层扫描(CT)的放射组学特征对三阴性乳腺癌(TNBC)的诊断价值,以便更好地治疗乳腺癌患者。

方法

回顾性分析 2016 年 6 月至 2018 年 1 月我院收治的 890 例乳腺癌患者,均经手术及病理检查确诊为肿块型及浸润性乳腺癌,术前均行胸部增强 CT 检查。随机抽取其中 300 例患者进行研究,包括 100 例 TNBC 患者和 200 例非 TNBC(NTNBC)患者。其中 180 例用于发现组,120 例用于验证组。采用免疫组织化学法确定乳腺癌患者的分子亚型。从三维 CT 图像中提取放射组学特征。采用 LASSO 逻辑回归方法筛选图像特征并计算放射组学评分。绘制受试者工作特征(ROC)曲线分析放射组学评分对 TNBC 的诊断价值。

结果

发现 5 个与 TNBC 亚型相关的图像特征(P<0.001)。基于这些图像特征的放射组学特征对 TNBC 有较好的预测价值,发现组的 ROC 曲线下面积(AUC)为 0.881(95%CI:0.781-0.921),验证组为 0.851(95%CI:0.761-0.961)。发现组的敏感度和特异度分别为 0.767 和 0.873,验证组分别为 0.785 和 0.915。

结论

基于术前 CT 的放射组学特征能够区分 TNBC 和 NTBG 患者,为常规胸部增强 CT 增加了附加价值,有助于制定患者的临床治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ec/7309976/c9c04c9ad293/12885_2020_7053_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ec/7309976/6733c2526d93/12885_2020_7053_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ec/7309976/c9c04c9ad293/12885_2020_7053_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ec/7309976/6733c2526d93/12885_2020_7053_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ec/7309976/c9c04c9ad293/12885_2020_7053_Fig2_HTML.jpg

相似文献

1
Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography.基于术前增强胸部 CT 提取的放射组学特征诊断三阴性乳腺癌。
BMC Cancer. 2020 Jun 22;20(1):579. doi: 10.1186/s12885-020-07053-3.
2
A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer.基于 X 射线钼靶的放射组学技术在三阴性乳腺癌患者中的初步研究。
J Xray Sci Technol. 2019;27(3):485-492. doi: 10.3233/XST-180488.
3
Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer.基于乳腺 X 线摄影的放射组学特征在前哨淋巴结阴性三阴性乳腺癌中的应用。
BMC Med Imaging. 2022 Sep 14;22(1):166. doi: 10.1186/s12880-022-00875-6.
4
Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.基于 DCE-MRI 自动图像分割的放射组学分析预测三阴性和非三阴性乳腺癌。
Comput Math Methods Med. 2021 Aug 10;2021:2140465. doi: 10.1155/2021/2140465. eCollection 2021.
5
Radiomic analysis on magnetic resonance diffusion weighted image in distinguishing triple-negative breast cancer from other subtypes: a feasibility study.磁共振弥散加权图像纹理分析鉴别三阴性乳腺癌与其他亚型的可行性研究。
Clin Imaging. 2021 Apr;72:136-141. doi: 10.1016/j.clinimag.2020.11.024. Epub 2020 Nov 14.
6
Contrast-Enhanced Mammography Radiomics Analysis for Preoperative Prediction of Breast Cancer Molecular Subtypes.对比增强乳腺 X 线摄影影像组学分析在乳腺癌分子亚型术前预测中的应用。
Acad Radiol. 2024 Jun;31(6):2228-2238. doi: 10.1016/j.acra.2023.12.005. Epub 2023 Dec 23.
7
Predictive value of triple negative breast cancer based on DCE-MRI multi-phase full-volume ROI clinical radiomics model.基于 DCE-MRI 多期全容积 ROI 临床放射组学模型的三阴性乳腺癌预测价值。
Acta Radiol. 2024 Feb;65(2):173-184. doi: 10.1177/02841851231215145. Epub 2023 Nov 28.
8
Intratumoral and Peritumoral Edema Radiomics Based on Fat-Suppressed T2- Weighted Imaging for Preoperative Prediction of Triple-Negative Breast Cancer.基于抑脂 T2WI 的肿瘤内及肿瘤周围水肿影像组学在三阴性乳腺癌术前预测中的应用。
Curr Med Imaging. 2024;20:e15734056293294. doi: 10.2174/0115734056293294240417100820.
9
Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.基于动态对比增强 MRI 的放射组学术前预测浸润性乳腺癌的淋巴管血管侵犯。
J Magn Reson Imaging. 2019 Sep;50(3):847-857. doi: 10.1002/jmri.26688. Epub 2019 Feb 17.
10
MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.MRI 放射组学特征:与三阴性乳腺癌患者无病生存的相关性。
Sci Rep. 2020 Feb 28;10(1):3750. doi: 10.1038/s41598-020-60822-9.

引用本文的文献

1
Radiologic imaging biomarkers in triple-negative breast cancer: a literature review about the role of artificial intelligence and the way forward.三阴性乳腺癌的放射影像学生物标志物:关于人工智能作用及未来发展方向的文献综述
BJR Artif Intell. 2024 Nov 13;1(1):ubae016. doi: 10.1093/bjrai/ubae016. eCollection 2024 Jan.
2
Assessment of CuFeSe ternary nanozymes for multimodal triple negative breast cancer theranostics.用于多模态三阴性乳腺癌诊疗的CuFeSe三元纳米酶评估
Nano Converg. 2025 Apr 2;12(1):18. doi: 10.1186/s40580-025-00483-4.
3
CT-based radiomics for predicting breast cancer radiotherapy side effects.

本文引用的文献

1
Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer.综合蛋白质组学特征揭示三阴性乳腺癌中的亚型特异性分子异常。
iScience. 2020 Feb 21;23(2):100868. doi: 10.1016/j.isci.2020.100868. Epub 2020 Jan 28.
2
Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.数字成像辅助检测 H3K27me3 在腔 A/B 样、HER2 阴性、浸润性乳腺癌中的免疫表达,可预测患者的生存和复发风险。
Mol Med. 2020 Feb 12;26(1):22. doi: 10.1186/s10020-020-0147-5.
3
基于 CT 的放射组学预测乳腺癌放疗副作用。
Sci Rep. 2024 Aug 29;14(1):20051. doi: 10.1038/s41598-024-70723-w.
4
The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)影像组学在预测食管癌患者新辅助治疗的病理反应中的作用。
Rep Pract Oncol Radiother. 2024 Jun 6;29(2):211-218. doi: 10.5603/rpor.99906. eCollection 2024.
5
Prediction of the axillary lymph-node metastatic burden of breast cancer by F-FDG PET/CT-based radiomics.基于 F-FDG PET/CT 影像组学预测乳腺癌腋窝淋巴结转移负荷
BMC Cancer. 2024 Jun 7;24(1):704. doi: 10.1186/s12885-024-12476-3.
6
Utilizing grayscale ultrasound-based radiomics nomogram for preoperative identification of triple negative breast cancer.利用基于灰阶超声的放射组学列线图术前识别三阴性乳腺癌。
Radiol Med. 2024 Jan;129(1):29-37. doi: 10.1007/s11547-023-01739-x. Epub 2023 Nov 2.
7
Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study.构建乳腺癌腋窝淋巴结转移的综合预测模型:一项回顾性研究。
BMC Cancer. 2023 Oct 24;23(1):1028. doi: 10.1186/s12885-023-11498-7.
8
Comparison of radiomics models and dual-energy material decomposition to decipher abdominal lymphoma in contrast-enhanced CT.对比增强 CT 中基于放射组学模型和双能量物质分解技术对腹部淋巴瘤的解读。
Int J Comput Assist Radiol Surg. 2023 Oct;18(10):1829-1839. doi: 10.1007/s11548-023-02854-w. Epub 2023 Mar 6.
9
A Simultaneous Multiparametric F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer.一种用于诊断三阴性乳腺癌的同时多参数F-FDG PET/MRI影像组学模型。
Cancers (Basel). 2022 Aug 16;14(16):3944. doi: 10.3390/cancers14163944.
10
AI in spotting high-risk characteristics of medical imaging and molecular pathology.人工智能在识别医学影像和分子病理学的高风险特征方面的应用。
Precis Clin Med. 2021 Dec 4;4(4):271-286. doi: 10.1093/pcmedi/pbab026. eCollection 2021 Dec.
Breast cancer.
乳腺癌。
Nat Rev Dis Primers. 2019 Sep 23;5(1):66. doi: 10.1038/s41572-019-0111-2.
4
Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression.基于p53免疫组化表达的乳腺癌亚型重新分类的临床病理及流行病学意义
NPJ Breast Cancer. 2019 Jul 25;5:20. doi: 10.1038/s41523-019-0117-7. eCollection 2019.
5
Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.基于 CT 影像的放射组学特征预测胃癌患者生存及化疗获益
EBioMedicine. 2018 Oct;36:171-182. doi: 10.1016/j.ebiom.2018.09.007. Epub 2018 Sep 14.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.微小 RNA 在早期三阴性乳腺癌的诊断和治疗监测中的作用。
Sci Rep. 2018 Aug 2;8(1):11584. doi: 10.1038/s41598-018-29917-2.
8
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies.我们应如何治疗早期三阴性乳腺癌(TNBC):从当前标准到即将出现的免疫分子策略。
ESMO Open. 2018 May 3;3(Suppl 1):e000357. doi: 10.1136/esmoopen-2018-000357. eCollection 2018.
9
Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features.基于乳腺影像组学特征的乳腺癌分子亚型预测。
Acad Radiol. 2019 Feb;26(2):196-201. doi: 10.1016/j.acra.2018.01.023. Epub 2018 Mar 8.
10
Rapid review: radiomics and breast cancer.快速回顾:放射组学与乳腺癌。
Breast Cancer Res Treat. 2018 Jun;169(2):217-229. doi: 10.1007/s10549-018-4675-4. Epub 2018 Feb 2.